Hong Kong Insurance Stock News

As global markets experience a shift toward optimism following the U.S.-Iran ceasefire, Asian markets have also seen positive momentum, supported by easing geopolitical tensions and renewed investor confidence. In this environment, growth companies with high insider ownership in Asia present intriguing opportunities, as insider stakes often indicate strong alignment between management and shareholder interests.

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

As global markets experience a shift in sentiment with easing geopolitical tensions and optimism around technological advancements, Asian stocks have shown resilience, setting the stage for potential investment opportunities. In this environment, identifying undervalued stocks becomes crucial as investors look for equities that may offer value despite broader market fluctuations.

As global markets experience a boost in sentiment following a U.S.-Iran ceasefire agreement, investors are increasingly eyeing opportunities across various sectors. Penny stocks, often representing smaller or newer companies, remain an intriguing area for those seeking affordability and potential growth. Despite being considered somewhat niche today, these stocks can still offer compelling opportunities when backed by strong financial health and resilience.

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) is back in focus after presenting Phase II data for its TROP2 ADC sacituzumab tirumotecan with pembrolizumab in ovarian and cervical cancer at the 2026 Society of Gynecologic Oncology meeting. See our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical. The strong Phase II data appears to sit alongside building momentum in the shares, with a 30.30% year to date share price return and a 1 year total shareholder return of 82.90% at a...

WuXi Biologics (Cayman) (SEHK:2269) recently obtained ISO 13485:2016 certification for its medical device quality management system with zero non conformities, an event that draws attention to how quality and compliance feed into its equity story. See our latest analysis for WuXi Biologics (Cayman). The ISO 13485:2016 win comes as the share price trades at HK$37.18, with a 1 month share price return of 6.41% and a year to date share price return of 14.26%. Over a longer horizon, the 1 year...

MiniMax Group overview and recent trading context MiniMax Group (SEHK:100) has drawn fresh attention after recent volatility, with a 6.3% gain over the past day contrasting with weaker moves over the past week and month. See our latest analysis for MiniMax Group. The recent 6.3% one day share price return comes after a weaker patch, with the 7 day and 30 day share price returns of 9.8% and 12.8% sitting against a very strong 90 day share price return of 105.6% and year to date share price...

Latest FY 2025 earnings snapshot NetEase (SEHK:9999) has just wrapped up FY 2025 with fourth quarter revenue of C¥27.5b and basic EPS of C¥1.96, rounding out a trailing twelve month revenue base of C¥112.6b and EPS of C¥10.59. Over the last six reported quarters, revenue has ranged from C¥26.2b in Q3 2024 to C¥28.8b in Q1 2025, while quarterly EPS has moved between C¥2.04 and C¥3.25. This gives investors a clear view of how the earnings line has tracked the top line. With trailing net profit...

Geopolitical shock hits Tencent shares Emerging market stocks came under pressure after the US ordered a blockade of the Strait of Hormuz following failed peace talks with Iran, and Tencent Holdings (SEHK:700) was among the technology names caught in the broad selloff. See our latest analysis for Tencent Holdings. At a share price of HK$517.0, Tencent’s 1 day share price return of 3.61% contrasts with a 30 day share price return decline of 6.00% and a year to date share price return decline...

NetEase Cloud Music (SEHK:9899) has posted its FY 2025 results with second half revenue of C¥3,932.3 million and basic EPS of C¥4.08, while investors also have a full year view from trailing 12 month revenue of C¥7,759.5 million and EPS of C¥13.02. The company has seen revenue move from C¥3,879.7 million and EPS of C¥3.60 in the second half of FY 2024 to C¥3,932.3 million and EPS of C¥4.08 in the latest half, with the trailing 12 month EPS rising from C¥7.48 to C¥13.02 alongside a net profit...

Share repurchase launch puts Horizon Robotics in focus Horizon Robotics (SEHK:9660) has begun repurchasing shares under a shareholder mandated program that authorizes buybacks of up to 10% of its issued share capital, drawing fresh attention to the stock. See our latest analysis for Horizon Robotics. At a latest share price of HK$7.17, Horizon Robotics has had a 1 day share price return of 0.84% and a 90 day share price decline of 23.56%, while its 1 year total shareholder return of 29.89%...

If you are wondering whether Agricultural Bank of China shares offer good value right now, the key is to separate headline performance from what the current price actually implies. The stock last closed at HK$6.00, with returns of 4.9% over 7 days, 13.9% over 30 days, 2.9% year to date, 40.4% over 1 year, 148.0% over 3 years and 184.9% over 5 years, which is likely to have caught the attention of many investors. These returns have put Agricultural Bank of China on the radar of market...

Cathay Pacific Airways stock triggered overview Cathay Pacific Airways (SEHK:293) has recently drawn investor attention after posting annual revenue of HK$116,766.0 million and net income of HK$10,828.0 million. This has put fresh focus on how its share performance lines up with these fundamentals. See our latest analysis for Cathay Pacific Airways. The share price has been under pressure in recent months, with a 30 day share price return of 5.52% and a year to date share price return of...

Hansoh Pharmaceutical Group (SEHK:3692) has secured NMPA approval for XINYUE’s third indication, targeting adult patients with generalized myasthenia gravis, and expanding its rare autoimmune disease footprint supported by positive Phase III MINT trial data. See our latest analysis for Hansoh Pharmaceutical Group. The XINYUE approval lands at a time when the share price has climbed to HK$39.4, with a 30 day share price return of 21.6% and a 1 year total shareholder return of 82.34%. This...

Beijing Yunji Technology Co., Ltd. ( HKG:2670 ) is possibly approaching a major achievement in its business, so we...

The market for Swire Pacific Limited's ( HKG:19 ) shares didn't move much after it posted weak earnings recently. We...

Amid improving global market sentiment following a U.S.-Iran ceasefire agreement, Asian markets have shown resilience and potential for growth. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials.

Wondering whether BYD at HK$107.30 is a bargain or a value trap? This article breaks down what the current price really implies about the stock. The share price recently closed at HK$107.30, with returns of 0.5% over 7 days, 2.9% over 30 days, 8.7% year to date, a 10.5% decline over the past year, 44.6% gains over 3 years and 87.0% gains over 5 years. Recent coverage has focused on BYD as a major player in electric vehicles and batteries, with investors weighing its role in global EV...

Lenovo Group (SEHK:992) has formed an alliance with Konecta to develop AI powered digital workplace solutions. The partnership focuses on an integrated model for IT outsourcing and digital workplace services using AI platforms. The collaboration is set to affect more than 100,000 employees across a global footprint. The move aligns with Lenovo’s broader shift toward services led and outcome based business models. For Lenovo Group, best known for PCs, infrastructure and devices, the alliance...

Global markets have recently experienced a boost in investor sentiment, driven by a ceasefire agreement between the U.S. and Iran, which has helped ease geopolitical tensions and lower oil prices. As major indices like the Nasdaq Composite see significant gains, investors are increasingly looking for opportunities that balance risk with potential rewards. Though "penny stocks" might seem like an outdated term, they continue to offer intriguing prospects for growth. These stocks often...

As global markets respond positively to a U.S.-Iran ceasefire, investor sentiment has improved, leading to gains across major indices. In this context, penny stocks—often representing smaller or newer companies—can still offer intriguing opportunities for growth when backed by solid financial health. Despite being considered a niche investment area today, these stocks can provide value and potential upside for those looking beyond larger firms.

Aluminum Corporation of China (SEHK:2600) issued first quarter 2026 earnings guidance, flagging net profit of CN¥5,302 million to CN¥5,585 million and basic EPS of CN¥0.310 to CN¥0.326, both implying 50% to 58% year-on-year growth. See our latest analysis for Aluminum Corporation of China. The earnings guidance comes after a sharp re-rating, with the 1-year total shareholder return of about 3x and a more muted share price return of 0.32% year to date at HK$12.68. Recent 7-day strength...

Luye Pharma Group (SEHK:2186) has drawn fresh attention after reporting the first patient enrollment in a Phase II trial in China for LY03020, a dual TAAR1 and 5-HT2CR agonist targeting schizophrenia. See our latest analysis for Luye Pharma Group. The LY03020 trial update comes as Luye Pharma Group’s share price sits at HK$2.89, with a 30-day share price return of 18.93% contrasting with a 90-day share price decline of 3.99%. The 1-year total shareholder return of 55.38% stands against a...

Why Xiaomi’s stock is drawing fresh attention Xiaomi (SEHK:1810) is back on investors’ radar after recent trading left the share price lower over the past month and the past 3 months, prompting closer scrutiny of its current valuation and business mix. See our latest analysis for Xiaomi. At the latest share price of HK$30.88, Xiaomi’s recent 30 day share price return of 7.32% and year to date share price return of 23.34% contrast with a 3 year total shareholder return of 148.23%. This...